The use of cell free DNA (cfDNA) for mutational screening of multiple myeloma

Multiple myeloma (MM) is an incurable haematological malignancy which relies heavily on bone marrow biopsies for disease monitoring and prediction of treatment response. In recent years, liquid biopsy derived cell-free DNA (cfDNA) has emerged as alternative for invasive biopsies. This pilot study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Marivel, A-M Joëlle, Ma, Yafeng, Becker, Therese M., Verma, Anvita, Trieu, Steven, Roberts, Tara L., Ling, Silvia C.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613886/
https://www.ncbi.nlm.nih.gov/pubmed/37908506
http://dx.doi.org/10.1016/j.lrr.2023.100393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613886/
https://www.ncbi.nlm.nih.gov/pubmed/37908506
http://dx.doi.org/10.1016/j.lrr.2023.100393

Ejemplares similares